Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1485 (LINC01485)

Target
LINC01485
Molecular classification
Other (long intergenic non-coding RNA; lncRNA; non-protein coding RNA)
01

Overview

Long intergenic non-protein coding RNA 1485 (LINC01485) is a cytoplasmic long intergenic non-coding RNA that does not encode a protein but functions in the regulation of diverse cellular processes. It is significantly upregulated in several cancers, particularly gastric cancer and colorectal cancer, where it enhances tumor growth, proliferation, migration, and invasion. Mechanistically, LINC01485 binds to and stabilizes epidermal growth factor receptor (EGFR) by blocking its ubiquitination and subsequent degradation, thereby sustaining EGFR/Akt signaling known to promote oncogenesis. It also acts as a molecular “sponge” for specific microRNAs (such as miR-383-5p in colorectal cancer), further enhancing oncogenic signaling through derepression of targets such as KRT80. LINC01485 is not a classic therapeutic molecular target (e.g., receptor, enzyme) but represents a possible non-coding RNA biomarker and a prospective nucleic acid therapeutic target in cancer research due to its key role in tumor progression[1][2][3][4].

Other names
CTB-43E15.4LINC01485
02

Biological functions

Regulation of gene expressionModulation of cell proliferationModulation of cell migrationModulation of apoptosisSignal transduction (indirect, via protein interaction)
03

Disease associations

Cancer (notably gastric cancer, colorectal cancer)
04

Safety considerations

Potential off-target effects if used therapeutically as a nucleic acid-based therapy are theoretical, but no data specific to LINC01485 are reported
05

Biomarkers

Potential biomarker for gastric cancer and colorectal cancer diagnosis and progression monitoring

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1485 (LINC01485).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1485 (LINC01485).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call